Julie Watson to Chair Commercialization Session During Wake Forest School of Medicine 2018 Regenerative Medicine Essentials Course
Special Counsel Julie M. Watson will chair the commercialization session of Wake Forest School of Medicine’s 5th Annual Regenerative Medicine Essentials Course.
Friday, June 8, 2018
Session 9: Commercialization
Wake Forest Bowman Gray Center for Medical Education
Winston-Salem, NC 27101
Ms. Watson will lead the commercialization session with co-instructors Gail Naughton, Ph.D., Chief Scientific Officer & Founder, Histogen, Inc., and Bernard Siegel, Executive Director, Regenerative Medicine Foundation. The commercialization session focuses on moving from research results to therapies in the clinic. Ms. Watson will provide an overview of intellectual property essentials for scientists and highlight special considerations for intellectual property in regenerative medicine.
To learn more about Wake Forest School of Medicine’s 5th Annual Regenerative Medicine Essentials Course, click here.
Julie M. Watson, Special Counsel and member of Marshall Gerstein’s IP Transactions practice group, concentrates on counseling related to intellectual property transactions with a particular emphasis in technology startups and university technology transfer. A licensing professional with over 25 years of experience structuring complex intellectual property transactions in-house, Ms. Watson has a deep appreciation of client needs and knows how to deliver strategic solutions.